文献速递产科母胎医学

叶酸临床试验母亲所生儿童的随访(FACT 4 儿童):基于双盲随机对照试验的前瞻性队列研究

Follow-Up of Children Born to Mothers in Folic Acid Clinical Trial (FACT 4 Child): A Prospective Cohort Study Based on a Double-Blinded Randomised Controlled Trial.
PubMed 文献 · BJOG · 2025-08-27

FACT 4 儿童研究是对国际多中心双盲随机试验FACT中母亲及其子女的随访,664名母亲完成随访,评估妊娠8+0至16+6周开始并持续至分娩的高剂量叶酸(4.0-5.1 mg)对4-9岁儿童孤独症谱系障碍相关社交障碍、执行功能缺陷及情绪行为问题的影响。干预组319名儿童中43名(13.5%)有评分升高,安慰剂组345名中51名(14.8%)有评分升高(RR=0.91;95%CI:0.63至1.33;p=0.63),两组神经发育结局无差异。

要点

  • 高剂量叶酸组13.5%儿童评分升高,安慰剂组14.8%,RR=0.91(95%CI:0.63至1.33;p=0.63)。
  • 在有子痫前期风险的女性中,高剂量叶酸与对照组的神经发育结局无差异。
  • 作者认为有子痫前期风险的孕妇可能不需要高剂量叶酸补充,需更大规模研究确定不同剂量和时机的神经发育结局。

核心结论

  • 在有子痫前期风险的女性所生儿童中,高剂量叶酸组与对照组的神经发育结局无差异。
  • 作者认为有子痫前期风险的孕妇可能不需要高剂量叶酸补充。
  • 需要更大规模的研究来确定妊娠期不同叶酸补充剂量和时机相关的神经发育结局。

研究设计与样本

  • FACT 4 儿童研究是国际多中心双盲随机试验FACT的随访研究,FACT旨在评估高剂量叶酸补充预防高危女性子痫前期的效果。
  • 共664名母亲及其子女完成随访。
  • 母亲使用标准化、经验证的量表报告4-9岁儿童的社交功能、执行功能及情绪行为问题。
  • 主要结局为至少一项评分超过预期均值1.5个标准差以上的儿童比例。

主要发现

  • 干预组319名儿童中43名(13.5%)有评分处于升高范围,安慰剂组345名中51名(14.8%)有评分处于升高范围(RR=0.91;95%CI:0.63至1.33;p=0.63)。

临床怎么用

  • 作者认为有子痫前期风险的孕妇可能不需要高剂量叶酸补充。
  • 作者建议需要更大规模的研究来确定妊娠期不同叶酸补充剂量和时机相关的神经发育结局。

局限性

  • 需要更大规模的研究来确定妊娠期不同叶酸补充剂量和时机相关的神经发育结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact of high-dose folic acid supplementation (4.0-5.1 mg), started between 8+0 and 16+6 weeks of gestation and continued until delivery, on social impairments associated with Autism Spectrum Disorders, deficiencies in executive function, and emotional and behavioural problems in children. DESIGN: FACT 4 Child is a follow-up of mothers and their children born during the Folic Acid Clinical Trial (FACT), an international multi-centre double-blinded randomised trial to assess the effect of high-dose folic acid supplementation on preventing preeclampsia in women with increased risk. SETTING: Multi-centre international follow-up study. POPULATION: Mothers and their children enrolled in FACT, among them 664 completed the follow-up. METHODS: Mothers reported on social and executive function and emotional and behavioural problems in their children aged 4-9 years using standardised, validated questionnaires. MAIN OUTCOME: The proportion of children with at least one score > 1.5 SD above expected mean. RESULTS: Among 319 children in the intervention group, 43 (13.5%) had a score in the elevated range, compared with 51/345 (14.8%) in the placebo group (RR = 0.91; 95% CI: 0.63 to 1.33; p = 0.63). CONCLUSION: In children born to women at risk for preeclampsia, rates of neurodevelopmental outcomes were not different between high-dose folic acid and control groups in this study. Our finding suggests that a high dose of folic acid supplementation may not be needed in pregnant women with increased risk. A larger-scale study is needed to determine neurodevelopmental outcomes associated with different dosages and timing of folic acid supplementation during pregnancy.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Ghiasi M, Zwaigenbaum L, Moddemann D, et al. Follow-Up of Children Born to Mothers in Folic Acid Clinical Trial (FACT 4 Child): A Prospective Cohort Study Based on a Double-Blinded Randomised Controlled Trial. BJOG. 2025. PMID: 40859816. doi:10.1111/1471-0528.18341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。